Feed - News and features

• WCLC: Biomarker could guide Dato-DXd use in lung cancer
  A biomarker could help identify...
• NICE clears NHS use of MSD's Welireg for genetic disorder
  Patients in England and Wales with a...
• WCLC: Summit trumpets data with Keytruda challenger
  MSD's PD-1 inhibitor Keytruda has...
• WCLC: MSD/Daiichi build case for phase 3 ADC for lung cancer
  MSD and Daiichi Sankyo have revealed...

News | PharmaTimes

• ChatGPT outperforms trainee doctors in assessing respiratory illness in children
• Eli Lilly’s once-weekly insulin shows promise in phase 3 trials
• AMBLor prognostic melanoma biomarker receives UKCA Mark
• European Commission grants orphan drug designation for Vivet’s VTX-806
• Acelyrin’s izokibep for hidradenitis suppurativa reveals positive results

• Brain Visual Perception Training for Prevention and Control of Premyopia
• Alveolar Cleft Reconstruction With Cortical-Shells
• Efficacy of a Quadruple Immunosuppressor Regimen With mTOR Inhibitors in Sensitized Kidney Transplant Patients
• Clinical Study on the Safety and Efficacy of TS-2021 in the Treatment of Recurrent Malignant Glioma